同样纠结的 #74: 维坦尼亚 索姆尼费拉 (阿什瓦甘达)
Sartaj Jhooty1, Paul Barkhaus2, Andrew Brown3
1Department of Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Amyotrophic lateral sclerosis & frontotemporal degeneration
|February 6, 2024
概括
维坦尼亚·索姆尼费拉 (阿什瓦甘达) 在减缓ALS进展方面表现有前途. 临床前研究和有限的人类使用表明适度的益处没有严重的副作用,保证进一步的临床试验.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病.
- 患者经常探索替代和非标签治疗方法.
研究的目的:
- 审查Withhania somnifera (WS) 的潜力,也被称为阿什瓦甘达,作为ALS治疗.
- 评估临床前和初步的人类数据的WS对ALS.
主要方法:
- 对WS对炎症,氧化应激,自,线粒体功能和亡的影响的文献综述.
- 对ALS临床前动物模型的分析.
- 对个人使用WS治疗ALS的事报告的审查.
主要成果:
- WS显示了减缓ALS进展的可信机制.
- 在动物模型中进行的临床前试验显示疾病进展减缓.
- 五分之二的人报告了WS的中度益处,没有显著的副作用.
结论:
- 维坦尼亚·索姆尼费拉 (阿什瓦甘达) 显示出作为对ALS的安全和低成本辅助疗法的潜力.
- 需要进一步的临床试验来确认ALS患者的疗效.
相关概念视频
Analgesia and Pain Management
623
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
623
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K


